For research use only · Not for human consumption
This material is reference information for laboratory study of research peptides. It is not medical advice and it is not instructions for human use, self-administration, or therapeutic application. Capital Peptides supplies research chemicals for in-vitro and animal-model study only. Discuss any health-related questions with a licensed medical practitioner.
1. Why cycling off matters
Unlike vitamins or basic supplements, research peptides interact with biological signalling systems that adapt to sustained stimulation. Continuous use without breaks can lead to:
- Receptor downregulation. When a receptor is chronically overstimulated, cells reduce the number of receptors expressed (downregulation) and/or reduce receptor sensitivity. The same dose produces a progressively weaker response.
- Pituitary desensitisation (GH-axis). Continuous GHRH stimulation (CJC-1295, sermorelin) can reduce the pituitary's responsiveness to the signal over time. Pulsed dosing or cycling off restores sensitivity.
- Baseline suppression. Some GH secretagogues used continuously may mildly suppress endogenous GHRH production. Cycling off allows natural patterns to normalise.
- Hormonal axis recalibration. The body's endocrine systems are self-regulating. Extended continuous exogenous stimulation eventually produces compensatory responses that work against the desired effect.
💡 Tip: The primary goal of cycling is maintaining long-term efficacy, not short-term safety. A protocol that still works at month 12 is better than one that produced great results for 3 months then stopped.
2. On/off ratio guide
| Protocol type | On period | Off period | Notes |
|---|---|---|---|
| Standard cycle | 8–12 weeks | 4–8 weeks | Most common approach for GH-axis and healing peptides |
| Short cycle | 4–6 weeks | 4 weeks | Useful for testing a new compound or targeted acute use |
| Long cycle | 16–20 weeks | 8–12 weeks | Used for body composition goals needing extended time; less common |
| 5 days on / 2 off | 5 days per week | Weekend break | Used for some cognitive peptides (Semax, Selank) to maintain weekday sensitivity |
| Continuous with dose holidays | Ongoing | 1 week off per month | Sometimes used for peptides with very long half-lives (CJC-1295 with DAC) |
These are general guidelines. Optimal cycling varies by compound, goal, and individual response. The research overviews for each peptide include specific recommendations where available.
3. Typical cycles by peptide class
| Peptide class | Typical cycle | Typical off period |
|---|---|---|
| GH secretagogues (CJC, Ipa, GHRP) | 8–12 weeks | 4–8 weeks |
| BPC-157 (acute injury) | 4–6 weeks | Until re-injury or 4+ weeks |
| BPC-157 (chronic/gut) | 8–12 weeks | 4–8 weeks |
| TB-500 | 4–8 weeks | 4+ weeks |
| GLP-1 agonists (semaglutide) | Ongoing (medical) or 12–20 weeks | Monitor — weight often returns |
| Semax, Selank | 4–8 weeks or 5 days/week ongoing | 1–2 weeks off monthly |
| Epithalon (bioregulator) | 10–20 days (traditional protocol) | 6 months+ |
| PT-141 | As needed — not continuous | Not a daily compound |
4. Signs it's time to cycle off
- Results have plateaued for 3–4 weeks despite consistent dosing and lifestyle
- You're no longer noticing any effects you noticed earlier in the cycle
- You have reached your planned cycle endpoint
- Side effects have become bothersome and dose reduction didn't help
- New side effects appearing later in the cycle (carpal tunnel, persistent water retention) suggest the body is not recovering adequately
ℹ️ Note: Absence of side effects is not a reason to stay on longer. The plateau in results is a more useful signal — side effects often reduce as the body adapts, but results plateau when receptor sensitivity reduces.
5. What to do between cycles
The off period is not wasted time — it's part of the protocol:
- Maintain training and nutrition. Results from a GH-axis cycle are largely retained if you continue training through the off period.
- Get bloodwork. The off period is ideal for checking that hormones and metabolic markers have returned to baseline.
- Assess results honestly. Using the journal you kept during the cycle, compare starting and ending metrics. This informs whether to repeat the same protocol, adjust dose, or switch compounds.
- Plan the next cycle. If stacking, the off period from one compound doesn't mean stopping all research. For example, coming off a GH secretagogue cycle while continuing a BPC-157 healing protocol is a common approach.